Is Beijing Kexing from China or foreign?

Beijing Kexing Biological Products Co., Ltd. is a biotechnology high-tech enterprise jointly funded by Kexing Holdings (Hong Kong) Co., Ltd. and Beijing Peking University Weiming Biological Engineering Group Co., Ltd. The company is registered in Peking University Biological City, Zhongguancun High-tech Park, Beijing, 200 1.

Beijing Kexing Investment Control Company is the first vaccine enterprise listed on foreign stock exchanges in China. In addition, Beijing Kexing Biopharmaceutical Co., Ltd. also has a subsidiary named Tangshan Yinan Biotechnology Co., Ltd., whose main business is product development and manufacturing of veterinary vaccines.

Research and development of Beijing Kexing

Beijing Branch has established a professional R&D and management system, and formed an R&D model with enterprises as the main body and Industry-University-Research as the combination. We have successful experience and technical team in the research and development of new vaccines, insist on independent innovation to build core competitiveness, adopt advanced technology to continuously develop new vaccines and carry out technical transformation on traditional vaccines.

Beijing Kexing has successively undertaken more than 20 scientific research projects, including "Development of Inactivated SARS Vaccine", "Broad-spectrum Influenza Epidemic Vaccine" (863 Plan), "Avian Influenza Vaccine for Human Use", national major scientific and technological projects, national high-tech industrialization demonstration projects, national high-tech industrialization projects and major projects in Beijing, and successfully realized the industrialization of many scientific and technological achievements.